Similar companies
Income Statement (USD)
Q2 '24 | QoQ | |
---|---|---|
Revenue | 14.5B | 17.5% |
Gross Profit | 4.98B | 66% |
Cost of Revenue | 9.48B | 1.8% |
Operating expense | 8.16B | 11.5% |
Net Income | 1.37B | 0.1% |
EBITDA | 4.77B | 10.6% |
Balance Sheet (USD)
Q2 '24 | QoQ | |
---|---|---|
Total Assets | 142B | 4.7% |
Total Liabilities | 135B | 4.1% |
Total Equity | 6.78B | 15.3% |
Shares Outstanding | 1.77B | 0.1% |
Cash Flow (USD)
Q2 '24 | QoQ | |
---|---|---|
Cash from operations | 2.27B | 43.8% |
Cash from investing | -1.1B | 88.5% |
Cash from financing | -6.1B | 156.4% |
EPS
Financial Highlights for AbbVie in Q2 '24
AbbVie reported a revenue of 14.5B, which is a 17.5% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 4.98B, marking a 66% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 9.48B, a 1.8% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 8.16B, showing a 11.5% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 1.37B, showing a 0.1% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 4.77B, showing a 10.6% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for AbbVie with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.